SIGYN THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
SIGYN THERAPEUTICS, INC. (SIGY) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $113.33 thousand as of 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2020-11-09
- 2020-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $113.33K.
- 2020-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $66.00K.
- 2020-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $55.00K.
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $40.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2020-09-30 | $113.33K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $66.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $55.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $40.00K 10-Q · filed 2020-11-09 |
| 2019-06-30 | $121.00K 10-Q · filed 2019-11-12 |
| 2019-03-31 | $210.00K 10-Q · filed 2019-04-19 |
| 2018-12-31 | $120.00K 10-Q · filed 2020-11-09 |
| 2018-09-30 | $120.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $185.00K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $795.00K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $1.20M 10-K · filed 2020-03-30 |
| 2016-12-31 | $1.10M 10-K · filed 2019-04-01 |
| 2016-09-30 | $2.45M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $2.45M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $2.45M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $2.45M 10-Q · filed 2016-11-14 |
| 2015-09-30 | $2.45M 10-Q · filed 2015-12-21 |